Crossmark Global Holdings’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-8,200
Closed -$323K – 1445
2020
Q3
$323K Buy
8,200
+130
+2% +$4.2K 0.01% 976
2020
Q2
$255K Buy
8,070
+30
+0.4% +$1.12K 0.01% 1101
2020
Q1
$283K Sell
8,040
-100
-1% -$4.21K 0.01% 884
2019
Q4
$396K Sell
8,140
-2,510
-24% -$114K 0.01% 949
2019
Q3
$506K Sell
10,650
-100
-0.9% -$4.7K 0.01% 777
2019
Q2
$461K Sell
10,750
-500
-4% -$19.4K 0.01% 848
2019
Q1
$435K Buy
+11,250
New +$381K 0.01% 896

Other funds holding CSII

Crossmark Global Holdings's CSII Position: Q4 2020 in Review

Crossmark Global Holdings sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2020, closing a stake of 8,200 shares — an estimated $323K sold.

Crossmark Global Holdings first reported a position in CSII in Q1 2019 and held it in 7 quarters. The position peaked at $506K in Q3 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q4 2020.

  • Crossmark Global Holdings reported no remaining Cardiovascular Systems, Inc. position as of Q4 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 8,200 Cardiovascular Systems, Inc. shares in Q4 2020, an estimated $323K.
  • Crossmark Global Holdings first reported a position in Cardiovascular Systems, Inc. in Q1 2019 and held it in 7 quarters.
  • Crossmark Global Holdings's Cardiovascular Systems, Inc. position peaked at $506K in Q3 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2020.

Based on Crossmark Global Holdings's 13F filing for Q4 2020, filed 14 Jan 2021.